4 – DRUG TARGETS: MOLECULAR MECHANISMS OF DRUG ACTION

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/B978-012744481-9/50008-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and function of GABA(C) receptors: a comparison of native versus recombinant receptors.

  2001cited by this paper
• Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine.

  2001cited by this paper
• Mechanism of action of general anaesthetics--new information from molecular pharmacology.

  2001cited by this paper
• Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines.

  2001cited by this paper
• Low-dose combination therapy: the rationalization for an ACE inhibitor and a calcium channel blocker in higher risk patients.

  2001cited by this paper
• Allosteric modulation of Ca2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Cavβ subunits

  2001cited by this paper
• Overview of nicotinic receptors and their roles in the central nervous system.

  2001cited by this paper
• Development of gene drug delivery systems based on pharmacokinetic studies.

  2001cited by this paper
• Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation*

  2001cited by this paper
• Structure and regulation of voltage-gated Ca2+ channels.

  2000cited by this paper
• GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.

  2000cited by this paper
• Structure, function, and control of phosphoinositide-specific phospholipase C.

  2000cited by this paper
• Multiple actions of steroid hormones--a focus on rapid, nongenomic effects.

  2000cited by this paper
• Signalling through the insulin receptor.

  2000cited by this paper
• From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.

  2000cited by this paper
• Molecular Aspects of Muscarinic Receptor Dimerization

  2000cited by this paper
• STAT proteins and transcriptional responses to extracellular signals.

  2000cited by this paper
• Signaling mechanisms of cytokine receptors and their perturbances in disease.

  2000cited by this paper
• Antisense oligonucleotide technology: from EST to therapeutics.

  2000cited by this paper
• Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions.

  2000cited by this paper
• Regulation of adenylyl cyclase in the central nervous system.

  2000cited by this paper
• Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent.

  2000cited by this paper
• G-protein mediated gating of inward-rectifier K+ channels.

  2000cited by this paper
• The 'ABC' of GABA receptors.

  2000cited by this paper
• Development of antisense oligodeoxynucleotides for transplantation.

  2000cited by this paper
• The CLC chloride channel family

  1999cited by this paper
• Structure, Mechanism, and Regulation of Mammalian Adenylyl Cyclase*

  1999cited by this paper
• Structure and function of the CFTR chloride channel.

  1999cited by this paper
• The structure of the nuclear hormone receptors.

  1999cited by this paper
• ClC channels: leaving the dark ages on the verge of a new millennium.

  1999cited by this paper
• Cytokines and JAK-STAT signaling.

  1999cited by this paper
• Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action.

  1999cited by this paper
• Changes in properties and neurosteroid regulation of GABAergic synapses in the supraoptic nucleus during the mammalian female reproductive cycle

  1999cited by this paper
• Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site.

  1999cited by this paper
• Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons.

  1999cited by this paper
• Signalling through phosphoinositide 3-kinases: the lipids take centre stage.

  1999cited by this paper
• Characterization of a murine gene homologous to the bovine CaCC chloride channel.

  1999cited by this paper
• The Many Faces of G Protein Signaling*

  1998cited by this paper
• Molecular basis of receptor/G-protein-coupling selectivity.

  1998cited by this paper
• Utiliser un recepteur coupl aux protines G pour communiquer. Un succs volutif

  1998cited by this paper
• Identification of a Giα Binding Site on Type V Adenylyl Cyclase*

  1998cited by this paper
• Phosphoinositide 3-kinases: a conserved family of signal transducers.

  1997cited by this paper
• G PROTEIN BETA GAMMA SUBUNITS

  1997cited by this paper
• Effector Contributions to Gβγ-mediated Signaling as Revealed by Muscarinic Potassium Channel Gating

  1997cited by this paper
• A Novel Form of the G Protein β Subunit Gβ5 Is Specifically Expressed in the Vertebrate Retina*

  1996cited by this paper
• Evolutionary history of the ligand-gated ion-channel superfamily of receptors.

  1995cited by this paper
• Further evidence for multitopological localization of mammalian porin (VDAC) in the plasmalemma forming part of a chloride channel complex affected in cystic fibrosis and encephalomyopathy.

  1995cited by this paper
• The pharmacology of intracellular Ca2+-release channels

  1994cited by this paper
• The 12-transmembrane helix transporters.

  1993cited by this paper
• Signalling by receptor tyrosine kinases.

  1993cited by this paper
• Mechanisms of multifunctional signalling by G protein-linked receptors.

  1993cited by this paper
• Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets.

  1993cited by this paper
• Mutational analysis of muscarinic acetylcholine receptors: structural basis of ligand/receptor/G protein interactions.

  1993cited by this paper
• The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH3 rat pituitary tumour cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking of the stimulatory guanine-nucleotide-binding protei

  1992cited by this paper
• Amino‐terminal leucine‐rich repeats in gonadotropin receptors determine hormone selectivity.

  1991cited by this paper
• Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

  1991cited by this paper
• Model systems for the study of seven-transmembrane-segment receptors.

  1991cited by this paper
• Angiotensin converting enzyme: implications from molecular biology for its physiological functions.

  1991cited by this paper
• Coupling of a mutated form of the human beta 2-adrenergic receptor to Gi and Gs. Requirement for multiple cytoplasmic domains in the coupling process.

  1991cited by this paper
• Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation.

  1991cited by this paper
• Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.

  1990cited by this paper
• Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers.

  1990cited by this paper
• Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells.

  1990cited by this paper
• Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes.

  1990cited by this paper
• Resistance to multiple chemotherapeutic agents in human cancer cells.

  1988cited by this paper
• Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.

  1988cited by this paper
• Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states

  1987cited by this paper
• Pharmacology: Drug Actions and Reactions

  1983cited by this paper

• An Insight into Sesamolin: Physicochemical Properties, Pharmacological Activities, and Future Research Prospects

  2021cites this paper
• Planejamento, síntese e avaliação da atividade antimicrobiana de derivados furfurilidênicos frente a micro-organismos causadores de infecções hospitalares

  2013cites this paper